Literature DB >> 9317043

Spiralin, a mycoplasmal membrane lipoprotein, induces T-cell-independent B-cell blastogenesis and secretion of proinflammatory cytokines.

C Brenner1, H Wróblewski, M Le Henaff, L Montagnier, A Blanchard.   

Abstract

Mycoplasmas are bacteria which can cause respiratory, arthritic, and urogenital diseases. During the early phase of infection, mycoplasmas usually induce an inflammatory response and a humoral response preferentially directed against their membrane-bound, surface-exposed lipoproteins. In this report, we describe the effects on immune cells of spiralin, a well-characterized mycoplasmal lipoprotein. Purified spiralin stimulated the in vitro proliferation of human peripheral blood mononuclear cells and murine splenocytes. The stimulation pathway was probably different from that followed by Escherichia coli lipopolysaccharide because the effect of spiralin was not abolished by polymyxin B. Comparison of the effects of whole, native spiralin with those induced by proteinase K-digested spiralin or by the C-terminal half of spiralin (peptide p[13.5]T) revealed that the first half of the protein, which contains the lipoylated N terminus, is responsible for the mitogenic activity. In contrast to whole spiralin, proteinase K-digested spiralin did not trigger murine B-cell differentiation and immunoglobulin G and M secretion. Stimulation of human or murine immune cells led to early secretion of proinflammatory cytokines (human tumor necrosis factor alpha and murine interleukin 1 or 6). Spiralin induced the T-cell-independent blastogenesis of murine B cells but did not stimulate T cells. Altogether, our data demonstrate that spiralin possesses potent immunostimulating activity, similar to that reported for lipoproteins of pathogenic gracilicutes (gram-negative eubacteria; e.g., Borrelia burgdorferi OspA and E. coli Braun lipoprotein), and are consistent with the fact that lipoproteins are major antigens during mycoplasma infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317043      PMCID: PMC175619          DOI: 10.1128/iai.65.10.4322-4329.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Plasmid DNA and protein vaccination of mice to the outer surface protein A of Borrelia burgdorferi leads to induction of T helper cells with specificity for a major epitope and augmentation of protective IgG antibodies in vivo.

Authors:  W Zhong; K H Wiesmüller; M D Kramer; R Wallich; M M Simon
Journal:  Eur J Immunol       Date:  1996-11       Impact factor: 5.532

2.  Inhibition of spiralin processing by the lipopeptide antibiotic globomycin.

Authors:  L Béven; M Le Hénaff; C Fontenelle; H Wróblewski
Journal:  Curr Microbiol       Date:  1996-11       Impact factor: 2.188

3.  Purification and characterization of spiralin, the main protein of the Spiroplasma citri membrane.

Authors:  H Wróblewski; K E Johansson; S Hjérten
Journal:  Biochim Biophys Acta       Date:  1977-03-01

Review 4.  Experimental immunization against Lyme borreliosis with recombinant Osp proteins: an overview.

Authors:  A Sadziene; A G Barbour
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

Review 5.  The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator.

Authors:  M D Kramer; R Wallich; M M Simon
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

6.  Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.

Authors:  M V Norgard; L L Arndt; D R Akins; L L Curetty; D A Harrich; J D Radolf
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

7.  Comparative analysis of flow cytometric methods for apoptosis quantitation in murine thymocytes and human peripheral lymphocytes from controls and HIV-infected persons. Evidence for interference by granulocytes and erythrocytes.

Authors:  H Lecoeur; M L Gougeon
Journal:  J Immunol Methods       Date:  1996-10-30       Impact factor: 2.303

8.  Resistance to mycoplasmal lung disease in mice is a complex genetic trait.

Authors:  S C Cartner; J W Simecka; D E Briles; G H Cassell; J R Lindsey
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

9.  Natural killer cells induce activated murine B cells to secrete Ig.

Authors:  C M Snapper; H Yamaguchi; M A Moorman; R Sneed; D Smoot; J J Mond
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

10.  Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

View more
  12 in total

1.  Phase variations of the Mycoplasma penetrans main surface lipoprotein increase antigenic diversity.

Authors:  O Neyrolles; I Chambaud; S Ferris; M C Prevost; T Sasaki; L Montagnier; A Blanchard
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Genetic and biochemical characterization of glycerol uptake in mycoplasma mycoides subsp. mycoides SC: its impact on H(2)O(2) production and virulence.

Authors:  E M Vilei; J Frey
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

3.  Induction of cytokines and chemokines in human monocytes by Mycoplasma fermentans-derived lipoprotein MALP-2.

Authors:  A Kaufmann; P F Mühlradt; D Gemsa; H Sprenger
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Antigenic and genetic characterization of lipoprotein LppQ from Mycoplasma mycoides subsp. mycoides SC.

Authors:  E M Abdo; J Nicolet; J Frey
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

5.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

Review 6.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

7.  Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.

Authors:  P F Mühlradt; M Kiess; H Meyer; R Süssmuth; G Jung
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

8.  Exosomes released from Mycoplasma infected tumor cells activate inhibitory B cells.

Authors:  Chenjie Yang; Geetha Chalasani; Yue-Harn Ng; Paul D Robbins
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 9.  Molecular mechanisms of pathogenicity of Mycoplasma mycoides subsp. mycoides SC.

Authors:  Paola Pilo; Joachim Frey; Edy M Vilei
Journal:  Vet J       Date:  2006-12-06       Impact factor: 2.688

10.  Beta-D-glucoside utilization by Mycoplasma mycoides subsp. mycoides SC: possible involvement in the control of cytotoxicity towards bovine lung cells.

Authors:  Edy M Vilei; Ivone Correia; M Helena Ferronha; Daniela F Bischof; Joachim Frey
Journal:  BMC Microbiol       Date:  2007-04-17       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.